| Titolo |
Pubblicato in |
Anno |
| Validation of a small-size pooling approach targeting hospital surveillance of SARS-CoV-2 infection |
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY |
2020 |
| Multiple chemical sensitivity syndrome. A principal component analysis of symptoms |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
2020 |
| Evidence-based considerations exploring relations between sars-cov-2 pandemic and air pollution: Involvement of pm2.5-mediated up-regulation of the viral receptor ace-2 |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
2020 |
| The future of pharmacogenetics in the treatment of migraine |
PHARMACOGENOMICS |
2019 |
| Genetics of Obstructive Sleep Apnea: Vitamin D Receptor Gene Variation Affects Both Vitamin D Serum Concentration and Disease Susceptibility |
OMICS |
2019 |
| Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine |
CNS DRUGS |
2018 |
| Pharmacogenetic considerations for migraine therapies |
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY |
2018 |
| Single nucleotide polymorphism of gstp1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy |
RADIATION ONCOLOGY JOURNAL |
2018 |
| Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY |
2017 |
| Lasmiditan for the treatment of migraine |
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
2017 |
| Personalized medicine applied to forensic sciences: new advances and perspectives for a tailored forensic approach |
CURRENT PHARMACEUTICAL BIOTECHNOLOGY |
2017 |
| Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes |
ANTICANCER RESEARCH |
2017 |
| Stable Remission of Multiple Chemical Sensitivity Syndrome and Major Depression With Citalopram and 1-Month Deep Transcranial Magnetic Stimulation. A Case Report |
THE JOURNAL OF ECT |
2017 |
| Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients |
NEUROSCIENCE LETTERS |
2017 |
| Personalised healthcare: the DiMA clinical model |
CURRENT PHARMACEUTICAL BIOTECHNOLOGY |
2017 |
| Pre-treatment evaluation of 5-fluorouracil degradation rate. association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort |
ONCOTARGET |
2016 |
| CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy |
THE EURASIAN JOURNAL OF MEDICINE |
2016 |
| Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations |
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY |
2016 |
| The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer |
ANTI-CANCER DRUGS |
2016 |
| Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer |
ONCOTARGET |
2016 |
